Trials / Conditions / Narcolepsy Without Cataplexy

Narcolepsy Without Cataplexy

12 registered clinical trials studyying Narcolepsy Without Cataplexy — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Decreasing Nightmares in Adults With Narcolepsy NCT06383806	University of Utah	N/A
Completed	Narcolepsy Nightmare Study NCT05709873	Northwestern University	N/A
Completed	An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy NCT05055024	NLS Pharmaceutics	Phase 2
Completed	Awareness and Self-Compassion Enhancing Narcolepsy Treatment NCT04306952	Northwestern University	N/A
Suspended	'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy' NCT04419792	University of Dublin, Trinity College	—
Completed	Clarithromycin Mechanisms in Hypersomnia Syndromes NCT04026958	Emory University	Phase 2
Completed	Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia NCT03772314	Emory University	Phase 2
Completed	Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind St NCT02611687	Bioprojet	Phase 3
Completed	A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcole NCT02512588	Balance Therapeutics	Phase 2
Completed	Flumazenil for the Treatment of Primary Hypersomnia NCT01183312	Lynn Marie Trotti	Phase 1 / Phase 2
Recruiting	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168	Sanford Health	—
No Longer Available	Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Dayt NCT03433131	Harmony Biosciences Management, Inc.	—